Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1350957

registered interest
date	18/08/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reduce covid-19 vaccine wastage; and what action is taken with unused vaccines.
tabling member constituency	Birmingham, Ladywood
tabling member printed	Shabana Mahmood
uin	40820
answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>No vaccines should be wasted. All vaccination centres should have a backup list of people in the cohorts currently being vaccinated, who can be called in case doses would be wasted. This is in line with the Enhanced Service Specification for the COVID-19 vaccination programme 2020/21.</p><p>We have put in place robust mitigations throughout the vaccination programme to reduce wastage, manage expiry dates, and avoid vaccine destruction, including, where there is data to support it, looking at the extension of expiry dates.</p><p>The United Kingdom is also one of the largest donors to COVID-19 Vaccines Global Access (COVAX). We will donate at least 100 million surplus doses within the next year, with the first batch of five million already delivered last month.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 06/09/2021 11:43:56 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	3914 label Biography information for Shabana Mahmood

1351060

registered interest
date	18/08/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether NHS England plans to use the flu vaccine list to prioritise patients, including those with asthma, for the covid-19 booster vaccination.
tabling member constituency	Leeds Central
tabling member printed	Hilary Benn
uin	40603
answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) published interim advice on a potential Covid-19 booster vaccination programme on 30th June 2021 which can be found at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022/jcvi-interim-advice-potential-covid-19-booster-vaccine-programme-winter-2021-to-2022" target="_blank">https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022/jcvi-interim-advice-potential-covid-19-booster-vaccine-programme-winter-2021-to-2022</a></p><p> </p><p>The JCVI’s interim advice is that COVID-19 boosters are first offered to the most vulnerable. They advise a two-staged approach, with individuals in Stage 1 offered a COVID-19 booster vaccine as well as a flu vaccine, as soon as possible from September 2021, and individuals in Stage 2 offered a COVID-19 booster vaccine as soon as practicable after Stage 1, with equal emphasis on deployment of the flu vaccine where eligible. Adults aged over 50 years old, and those aged between 16 and 49 who are in an influenza or COVID-19 at-risk group, are included in Stage 2.</p><p>It is important to note that the JCVI’s advice is interim to inform planning, and this may be subject to change.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 06/09/2021 11:45:22 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	413 label Biography information for Hilary Benn

1351082

registered interest
date	18/08/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Influenza: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the effect of the expansion of eligibility for flu vaccination to the over 50s in (a) 2020-21 and (b) 2021-22.
tabling member constituency	Halton
tabling member printed	Derek Twigg
uin	40611
answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>Last winter, the seasonal flu programme was extended on 1 December 2020 to include those aged 50 to 64 years old who were not in a clinical risk group. Of this group, 35.2% were vaccinated by the end of the season, with an estimated 2,669,568 vaccinations given.</p><p>For the 2021/22 flu season, we will continue to vaccinate all 50 to 64 year olds and will build on record uptake rates from the 20/21 winter. As a result of earlier advice from the Joint Committee on Vaccination and Immunisation and building on lessons learnt, 50 to 64 year olds will be eligible to book their appointment from the beginning of the season to allow more people to get vaccinated earlier.</p><p>In total, over 35 million people will be eligible for a free seasonal flu vaccine this year. The Department is in regular contact with flu vaccine manufacturers to ensure there is a sufficient amount of flu vaccines available to meet uptake ambitions for eligible cohorts.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 40613 40614 question first answered 06/09/2021 11:36:34 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	429 label Biography information for Derek Twigg

1351084

registered interest
date	18/08/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Influenza: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department plans to take to improve uptake of the flu vaccination among people aged between 50 and 64 in 2021-22.
tabling member constituency	Halton
tabling member printed	Derek Twigg
uin	40613
answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>Last winter, the seasonal flu programme was extended on 1 December 2020 to include those aged 50 to 64 years old who were not in a clinical risk group. Of this group, 35.2% were vaccinated by the end of the season, with an estimated 2,669,568 vaccinations given.</p><p>For the 2021/22 flu season, we will continue to vaccinate all 50 to 64 year olds and will build on record uptake rates from the 20/21 winter. As a result of earlier advice from the Joint Committee on Vaccination and Immunisation and building on lessons learnt, 50 to 64 year olds will be eligible to book their appointment from the beginning of the season to allow more people to get vaccinated earlier.</p><p>In total, over 35 million people will be eligible for a free seasonal flu vaccine this year. The Department is in regular contact with flu vaccine manufacturers to ensure there is a sufficient amount of flu vaccines available to meet uptake ambitions for eligible cohorts.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 40611 40614 question first answered 06/09/2021 11:36:34 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	429 label Biography information for Derek Twigg

1351085

registered interest
date	18/08/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Influenza: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department (a) has taken and (b) plans to take to improve the uptake of the flu vaccine among people aged 50 to 64 in 2021-22.
tabling member constituency	Halton
tabling member printed	Derek Twigg
uin	40614
answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>Last winter, the seasonal flu programme was extended on 1 December 2020 to include those aged 50 to 64 years old who were not in a clinical risk group. Of this group, 35.2% were vaccinated by the end of the season, with an estimated 2,669,568 vaccinations given.</p><p>For the 2021/22 flu season, we will continue to vaccinate all 50 to 64 year olds and will build on record uptake rates from the 20/21 winter. As a result of earlier advice from the Joint Committee on Vaccination and Immunisation and building on lessons learnt, 50 to 64 year olds will be eligible to book their appointment from the beginning of the season to allow more people to get vaccinated earlier.</p><p>In total, over 35 million people will be eligible for a free seasonal flu vaccine this year. The Department is in regular contact with flu vaccine manufacturers to ensure there is a sufficient amount of flu vaccines available to meet uptake ambitions for eligible cohorts.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 40611 40613 question first answered 06/09/2021 11:36:34 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	429 label Biography information for Derek Twigg

1351233

registered interest
date	18/08/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the risk that routine requests by NHS vaccination centres for NHS and National Insurance numbers may make people who are in the UK illegally less likely to engage with the covid-19 vaccination programme.
tabling member constituency	Gravesham
tabling member printed	Adam Holloway
uin	40751
answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>No such assessment has been made.</p><p>However, a National Health Service (NHS) number or national insurance number is not needed to make a booking for a COVID-19 vaccine or when attending a vaccination appointment.</p><p>As vaccination against COVID-19 is offered to every eligible adult living in the United Kingdom free of charge, regardless of their immigration status. No immigration checks are needed to receive a COVID-19 vaccination and the NHS is not required to report undocumented migrants to the Home Office.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 06/09/2021 11:45:41 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1522 label Biography information for Adam Holloway

1351267

registered interest
date	18/08/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department have taken steps to enable people who participated in the Novavax covid-19 vaccine trials to travel internationally; and what support his Department has provided to the European Medicines Agency for the registration of that vaccine.
tabling member constituency	Henley
tabling member printed	John Howell
uin	40817
answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>The Government continues to make the case that anyone on a COVID-19 vaccine trial should be treated the same in terms of certification as someone who has received a deployed vaccine. Our Chief Medical Officer has written to all of his counterparts in the European Union and European Economic Community on this matter. Discussions are ongoing with other countries, including through groups such as the Group of Seven, the European Commission and the World Health Organisation to shape the approach taken around the world to sharing health status for travel.</p><p>The Vaccines Taskforce and the Medicines and Healthcare products Regulatory Agency (MHRA) are working with Novavax to help ensure their COVID-19 vaccine is authorised as quickly as possible. The decision to license a vaccine is made by the MHRA.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 41230 question first answered 06/09/2021 11:43:29 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1606 label Biography information for John Howell

1351320

registered interest
date	18/08/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent discussions he has had with his EU counterpart on accepting the Novavax covid-19 vaccine for international travel.
tabling member constituency	Battersea
tabling member printed	Marsha De Cordova
uin	41230
answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>The Government continues to make the case that anyone on a COVID-19 vaccine trial should be treated the same in terms of certification as someone who has received a deployed vaccine. Our Chief Medical Officer has written to all of his counterparts in the European Union and European Economic Community on this matter. Discussions are ongoing with other countries, including through groups such as the Group of Seven, the European Commission and the World Health Organisation to shape the approach taken around the world to sharing health status for travel.</p><p>The Vaccines Taskforce and the Medicines and Healthcare products Regulatory Agency (MHRA) are working with Novavax to help ensure their COVID-19 vaccine is authorised as quickly as possible. The decision to license a vaccine is made by the MHRA.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 40817 question first answered 06/09/2021 11:43:29 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4676 label Biography information for Marsha De Cordova

1351323

registered interest
date	18/08/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what criteria he plans to use to determine (a) whether to implement a booster covid-19 vaccination programme in autumn 2021 and (b) which population groups that programme should cover.
tabling member constituency	Forest of Dean
tabling member printed	Mr Mark Harper
uin	40741
answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) published interim advice on a potential COVID-19 booster vaccination programme on 30th June 2021 which can be found at the following link:</p><p><a href="https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022" target="_blank">https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022</a></p><p>The JCVI’s interim advice is that COVID-19 boosters should first be offered to the most vulnerable. The JCVI advises a two-staged approach, with individuals in Stage 1 offered a COVID-19 booster vaccine as well as a flu vaccine, as soon as possible from September 2021 and individuals in Stage 2 offered a COVID-19 booster vaccine as soon as practicable after Stage 1, with equal emphasis on deployment of the flu vaccine where eligible.</p><p>It is important to note that this is interim advice to inform planning and this advice may be subject to change before being finalised. Final decisions on the timing and scope and cohort eligibility, including the groups listed above, of any COVID-19 vaccine booster programme will be confirmed once the JCVI have provided their final advice, alongside considerations related to COVID-19 vaccine supply.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 06/09/2021 11:43:13 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1520 label Biography information for Mr Mark Harper

1351584

registered interest
date	18/08/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that people with a phobia of needles will be made aware of when a version of a covid-19 vaccine which does not require needles is approved for use.
tabling member constituency	Morley and Outwood
tabling member printed	Andrea Jenkyns
uin	41045
answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>The Department will ensure that a comprehensive announcement is made if a COVID-19 vaccine that can be delivered without the use of a needle is approved.</p><p> </p><p>The Medicines and Healthcare products Regulatory Agency continues to monitor and engage with developers and producers of both currently approved and new COVID-19 vaccines and offers scientific advice on new technical developments. We are unable to comment on products that are not approved for use in the United Kingdom due to commercial and market sensitivities surrounding the approval processes.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 06/09/2021 11:44:12 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4490 label Biography information for Dame Andrea Jenkyns